CDXS Codexis, Inc. - Common Stock
NASDAQ · Life Sciences Tools & Services · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 11, 2026
$1,36
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$0,96rendah 52m
$2,98tinggi 52m
Kapitalisasi Pasar (MRQ)
$124M
P/E (TTM)
-4.2
EPS (TTM)
$-0.32
Pendapatan (TTM)
$78M
lencana Anda
Rentang 52M
$1–$3
Peringkat Analis
BUY
Target Harga
$6
P/E
-4.2
ROE
-69.4%
Margin Laba Bersih
-39.6%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
CDXS Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$1.36
Kapitalisasi Pasar (MRQ)
$124M
P/E (TTM)
-4.2
EPS (TTM)
$-0.32
Pendapatan (TTM)
$78M
ROE (TTM)
-69.4%
D/E Utang/Ekuitas (MRQ)
1.2
Rentang 52M
$1–$3
CDXS Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Tentang Codexis, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
History
Codexis is based in Redwood City, CA and was incorporated in 2002. It went public in April 2010 on NASDAQ, and in October, acquired Maxygen's MolecularBreeding technology portfolio.
Pharmaceutical
Codexis won the Presidential Green Chemistry Challenge Award from the U.S. Environmental Protection Agency (EPA) in 2006 for its work on a building block of Lipitor. It then won a second time in 2010 for its work with Merck & Co. on the active ingredient in Januvia.
Nutrition
In 2017, the company entered a partnership with Tate & Lyle to provide research and development for the production of new ingredients. That same year, Codexis announced a collaboration with Nestle to provide enzymes for metabolic disorders.
Biotherapeutics
In 2017, Codexis developed a recombinant phenylalanine ammonia-lyase (PAL) enzyme, to act as a substitute phenylalanine hydroxylase (PAH) enzyme for people who suffer from phenylketonuria. The enzyme was in-licensed by Nestle Health Sciences.
In 2020, Takeda Pharmaceutical announced a collaboration with Codexis to research and create gene therapies for rare diseases, including lysosomal storage disorders.
Life science
In June 2020, they announced a partnership with Molecular Assemblies to engineer enzymes for DNA synthesis.
Technology
Codexis uses directed evolution to develop its enzymes. Using this method, scientists genetically engineer genes, then screen the enzymes produced to see if it creates the properties needed for a specific reaction. Their protein engineering platform, called CodeEvolver, uses machine learning and high-throughput experimentation to learn protein sequence changes and their impacts on protein function.
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
sektorHealthcare
industriLife Sciences Tools & Services
karyawan146
negaraUS
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$70M2016-12-31 → 2025-12-31
EPS$-0.502019-12-31 → 2025-12-31
Arus Kas Bebas$-24M2016-12-31 → 2025-12-31
Margin bersih-39.6%2016-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | CDXS | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | -4.2rata-rata 5T ≈-23.0 | ≈-23.0 | · | · | |
| P/S (TTM) | 1.6rata-rata 5T ≈6.7 | ≈6.7 | 4.2 | Kurang nilai | |
| P/B (MRQ) | 3.8rata-rata 5T ≈5.1 | ≈5.1 | 0.9 | Terlalu mahal | |
| EV / EBITDA (TTM) | -4.9 | · | · | · | |
| Harga / FCF (TTM) | -10.2rata-rata 5T ≈2.7 | ≈2.7 | · | · | |
| Harga / Arus Kas (TTM) | -11.9rata-rata 5T ≈-27.0 | ≈-27.0 | · | · | |
| EV / Pendapatan (TTM) | 1.4 | · | · | · | |
| EV / FCF (TTM) | -9.1 | · | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 2.6rata-rata 5T ≈5.3 | ≈5.3 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | CDXS | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Operasi (TTM) | -35.6%rata-rata 5T ≈-60.4% | ≈-60.4% | -140.7% | Tingkat teratas | |
| Margin EBITDA (TTM) | -28.9%rata-rata 5T ≈-57.2% | ≈-57.2% | -140.7% | Tingkat teratas | |
| Margin Sebelum Pajak (TTM) | -39.5%rata-rata 5T ≈-65.0% | ≈-65.0% | -122.0% | Tingkat teratas | |
| Margin Laba Bersih (TTM) | -39.6%rata-rata 5T ≈-65.1% | ≈-65.1% | -140.9% | Tingkat teratas | |
| ROA (TTM) | -23.8%rata-rata 5T ≈-27.5% | ≈-27.5% | -22.2% | Lemah | |
| ROE (TTM) | -69.4%rata-rata 5T ≈-59.3% | ≈-59.3% | -34.9% | Lemah | |
| ROIC | -46.1%rata-rata 5T ≈-44.8% | ≈-44.8% | -40.5% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | CDXS | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Utang / Ekuitas (MRQ) | 1.2 | · | · | · | |
| Rasio Lancar (MRQ) | 3.1rata-rata 5T ≈3.8 | ≈3.8 | 6.5 | Likuiditas rendah | |
| Quick Ratio (Rasio Cepat) | 3.1rata-rata 5T ≈3.1 | ≈3.1 | 1.8 | Likuiditas kuat | |
| Utang Jangka Panjang / Ekuitas (MRQ) | 1.0 | · | · | · |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | CDXS | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 18.6%rata-rata 5T ≈7.6% | ≈7.6% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | -20.2%rata-rata 5T ≈-12.3% | ≈-12.3% | · | · | |
| Revenue CAGR 5Y (CAGR Pendapatan 5T) | 0.38% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | CDXS | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.5rata-rata 5T ≈0.5 | ≈0.5 | 0.4 | Tingkat teratas | |
| Inventory Turnover (Perputaran Persediaan) | 5.2rata-rata 5T ≈12.5 | ≈12.5 | 1.9 | Tingkat teratas | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$482.1K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
15.7%
Laporan Berikutnya
Nov 04, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 11, 2026 | $-0.13 | $-0.14 | 7.7% |
| 31 Maret 2026 | Mei 12, 2026 | $-0.10 | $-0.14 | 28.3% |
| 31 Des. 2025 | $0.11 | $-0.04 | 357.0% | |
| 30 Sep. 2025 | $-0.22 | $-0.15 | -45.2% | |
| 30 Juni 2025 | $-0.16 | $-0.19 | 16.8% | |
| 31 Maret 2025 | $-0.25 | $-0.24 | -3.3% | |
| 31 Des. 2024 | $-0.13 | $-0.04 | -251.4% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $70M | $59M | $70M | $139M | $105M | $69M | $68M | $61M | $50M | $49M | $42M | $35M | |
| Cost of Revenue | $9M | $16M | $13M | $38M | $22M | $14M | $16M | $13M | $14M | $10M | $7M | $10M | |
| R&D Expense | $52M | $46M | $59M | $80M | $56M | $44M | $34M | $30M | $30M | $22M | $21M | $23M | |
| SG&A Expense | $47M | $55M | $53M | $52M | $49M | $35M | $32M | $29M | $29M | $25M | $22M | $22M | |
| Operating Expenses | $112M | $118M | $138M | $173M | $127M | $93M | $81M | $72M | $73M | $57M | $50M | $54M | |
| Operating Income | $-42M | $-59M | $-68M | $-35M | $-23M | $-24M | $-13M | $-11M | $-23M | $-9M | $-8M | $-19M | |
| Interest Income | $3M | $4M | $4M | $1M | $459.0K | $405.0K | $1M | $671.0K | $147.0K | $60.0K | $19.0K | $18.0K | |
| Other Non-op | $-5M | $-10M | $-12M | $124.0K | $1M | $-156.0K | $-656.0K | $-291.0K | $-92.0K | $-94.0K | · | · | |
| Pretax Income | $-44M | $-65M | $-76M | $-33M | $-21M | $-24M | $-12M | $-11M | $-23M | $-9M | $-8M | $-19M | |
| Income Tax | $47.0K | $34.0K | $69.0K | $276.0K | $189.0K | $339.0K | $17.0K | $-37.0K | $81.0K | $-40.0K | $-338.0K | $-256.0K | |
| Net Income | $-44M | $-65M | $-76M | $-34M | $-21M | $-24M | $-12M | $-11M | $-23M | $-9M | $-8M | $-19M | |
| EPS (Basic) | $-0.50 | $-0.89 | $-1.12 | $-0.51 | $-0.33 | $-0.40 | $-0.21 | · | · | · | · | · | |
| EPS (Diluted) | $-0.50 | $-0.89 | $-1.12 | $-0.51 | $-0.33 | $-0.40 | $-0.21 | · | · | · | · | · | |
| Shares (Basic) | 87,142,000 | 73,408,000 | 68,131,000 | 65,344,000 | 64,568,000 | 59,360,000 | 56,525,000 | · | · | · | · | · | |
| Shares (Diluted) | 87,142,000 | 73,408,000 | 68,131,000 | 65,344,000 | 64,568,000 | 59,360,000 | 56,525,000 | · | · | · | · | · | |
| EBITDA | $-36M | $-54M | $-68M | $-35M | $-23M | $-24M | $-13M | $-11M | $-23M | $-9M | $-8M | $-19M |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51M | $19M | $65M | $114M | $117M | $149M | $90M | $53M | $31M | $19M | $23M | $26M | |
| Short-term Investments | $27M | $54M | $0 | · | · | · | · | · | · | · | · | · | |
| Receivables | · | · | $10M | $32M | $25M | $14M | $9M | $12M | $11M | $6M | $7M | $4M | |
| Inventory | $2M | $2M | $3M | $2M | $1M | $964.0K | $371.0K | $589.0K | $1M | $825.0K | $992.0K | $1M | |
| Prepaid Expense | $6M | $4M | $5M | $5M | $6M | $3M | $3M | $1M | $984.0K | $1M | $1M | $1M | |
| Other Current Assets | $500.0K | $500.0K | $600.0K | $700.0K | · | · | · | · | · | · | · | · | |
| Current Assets | $97M | $99M | $93M | $163M | $162M | $184M | $114M | $68M | $45M | $27M | $33M | $33M | |
| PP&E (Net) | $13M | $14M | $15M | $23M | $21M | $10M | $6M | $5M | $3M | $2M | $3M | $4M | |
| PP&E (Gross) | $58M | $55M | $55M | $62M | $57M | $43M | $40M | $38M | $35M | $34M | $35M | $37M | |
| Accum. Depreciation | $45M | $41M | $39M | $40M | $36M | $33M | $33M | $33M | $32M | $32M | $32M | $31M | |
| Goodwill | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Intangibles | · | · | · | · | · | · | · | · | · | $0 | $3M | $6M | |
| Other Non-current Assets | $883.0K | $1M | $1M | $350.0K | $276.0K | $294.0K | $178.0K | $1M | $302.0K | $259.0K | $310.0K | $294.0K | |
| Total Assets | $148M | $149M | $137M | $250M | $246M | $222M | $149M | $79M | $54M | $36M | $45M | $48M | |
| Accounts Payable | $2M | $3M | $6M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $5M | |
| Accrued Liabilities | $3M | $6M | $5M | $15M | $13M | $10M | $7M | $5M | $4M | $2M | $2M | $3M | |
| Current Liabilities | $25M | $24M | $36M | $49M | $33M | $25M | $15M | $18M | $25M | $12M | $15M | $14M | |
| Capital Leases | $30M | $28M | $12M | $38M | $44M | $22M | $25M | $61.0K | $302.0K | · | · | · | |
| Other Non-current Liabilities | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $3M | |
| Total Liabilities | $97M | $82M | $50M | $106M | $82M | $52M | $44M | $23M | $29M | $17M | $22M | · | |
| Long-term Debt | $40M | $29M | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $40M | $29M | · | · | · | · | · | · | $302.0K | · | · | · | |
| Common Stock | $9.0K | $8.0K | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $657M | $630M | $584M | $566M | $552M | $537M | $448M | $387M | $340M | $311M | $306M | $302M | |
| Retained Earnings | $-607M | $-563M | $-498M | $-421M | $-388M | $-366M | $-342M | $-330M | $-315M | $-292M | $-284M | $-276M | |
| AOCI | $8.0K | $52.0K | $0 | · | · | · | · | $0 | $-472.0K | $0 | $405.0K | $-142.0K | |
| Stockholders' Equity | $51M | $67M | $87M | $145M | $164M | $170M | $106M | $56M | $25M | $19M | $23M | $26M | |
| Liabilities + Equity | $148M | $149M | $137M | $250M | $246M | $222M | $149M | $79M | $54M | $36M | $45M | $48M | |
| Shares Outstanding | 90,478,000 | 81,850,000 | 69,905,000 | 65,811,000 | 65,109,000 | 64,283,000 | 58,877,000 | 54,065,000 | 48,365,000 | 41,255,000 | 40,343,000 | 39,563,000 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $5M | $6M | $5M | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $10M | $13M | $10M | $15M | $12M | $8M | $7M | $8M | $7M | $6M | $5M | $5M | |
| Deferred Tax | $-3.0K | $-2.0K | $0 | $-7.0K | $-9.0K | $-8.0K | $-6.0K | $-29.0K | $12.0K | $-31.0K | $-330.0K | $110.0K | |
| Amort. of Intangibles | · | · | · | · | · | · | · | $0 | $0 | $3M | $3M | $3M | |
| Restructuring | $3M | $0 | $3M | $3M | $0 | $0 | · | · | · | · | · | · | |
| Other Non-cash | $10M | $-2M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-19M | $-49M | $-53M | $11M | $-14M | $-16M | $-13M | $-14M | $-9M | $-2M | $-433.0K | $321.0K | |
| CapEx | $4M | $4M | $4M | $8M | $14M | $4M | $4M | $3M | $985.0K | $888.0K | $1M | $302.0K | |
| Investing Cash Flow | $24M | $-57M | $-5M | $-14M | $-21M | $-6M | $-4M | $-3M | $-983.0K | $-846.0K | $-1M | $5M | |
| Debt Issued | $10M | $30M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $10M | $30M | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $17M | $31M | $9M | $0 | $0 | $86M | $0 | $37M | $24M | $0 | $0 | $9.0K | |
| Net Stock Activity | $17M | $31M | $9M | $0 | $0 | $86M | $50M | · | $24M | $0 | $0 | $9.0K | |
| Financing Cash Flow | $28M | $61M | $8M | $-575.0K | $4M | $81M | $54M | $39M | $22M | $-490.0K | $-2M | $-611.0K | |
| Net Change in Cash | $32M | $-46M | $-49M | $-3M | $-32M | $59M | $38M | $22M | $12M | $-3M | $-3M | $4M | |
| Taxes Paid | · | $17.0K | $194.0K | $100.0K | $102.0K | $312.0K | $5.0K | $5.0K | $32.0K | $5.0K | $8.0K | $15.0K | |
| Free Cash Flow | $-24M | $-54M | $-57M | $3M | $-28M | $-20M | $-16M | $-17M | $-10M | $-4M | $-2M | $19.0K |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -59.3% | -98.6% | -97.0% | -25.2% | -21.7% | -34.6% | -18.3% | -18.6% | -45.9% | -17.5% | -18.6% | -54.1% | |
| Net Margin | -62.5% | -110.0% | -108.7% | -24.2% | -20.3% | -34.8% | -17.4% | -17.9% | -46.0% | -17.5% | -18.1% | -54.0% | |
| Pretax Margin | -62.4% | -109.9% | -108.6% | -24.0% | -20.1% | -34.3% | -17.4% | -18.0% | -45.8% | -17.6% | -18.9% | -54.7% | |
| EBITDA Margin | -51.8% | -90.3% | -97.0% | -25.2% | -21.7% | -34.6% | -18.3% | -18.6% | -45.9% | -17.5% | -18.6% | -54.1% | |
| ROA | -29.6% | -45.7% | -39.4% | -13.5% | -9.1% | -13.0% | -10.4% | -16.4% | -51.5% | -21.3% | -16.3% | -35.7% | |
| ROE | -82.8% | -93.0% | -85.6% | -22.5% | -12.8% | -18.4% | -11.5% | -19.6% | -98.6% | -40.8% | -30.8% | -56.3% | |
| ROIC | -46.1% | -61.1% | -78.7% | -24.3% | -13.9% | -14.3% | -11.9% | -20.0% | -92.8% | -44.6% | -32.5% | -71.7% |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 4.2 | 2.6 | 3.3 | 4.9 | 7.4 | 7.4 | 3.8 | 1.8 | 2.2 | 2.2 | 2.4 | |
| Quick Ratio | 3.1 | 3.1 | 2.1 | 3.0 | 4.2 | 6.5 | 6.5 | 3.6 | 1.7 | 2.0 | 2.1 | 2.2 | |
| Debt / Equity | 0.8 | 0.4 | · | · | · | · | · | · | 0.0 | · | · | · | |
| LT Debt / Equity | 0.8 | 0.4 | · | · | · | · | · | · | 0.0 | · | · | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.4 | 0.6 | 0.4 | 0.4 | 0.6 | 0.9 | 1.1 | 1.2 | 0.9 | 0.7 | |
| Inventory Turnover | 5.2 | 7.3 | 5.4 | 23.9 | 20.9 | 20.6 | 32.6 | 15.5 | 15.4 | 10.7 | 5.5 | 6.7 | |
| Receivables Turnover | · | · | 3.3 | 4.9 | 5.4 | 6.0 | 6.7 | 5.3 | 5.6 | 7.4 | 7.5 | 7.6 |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.56 | $0.82 | $1.24 | $2.20 | $2.52 | $2.65 | $1.79 | $1.03 | $0.51 | $0.46 | $0.57 | $0.67 | |
| Revenue / Share | $0.81 | $0.81 | $1.03 | $2.12 | $1.62 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.22 | $-0.67 | $-0.77 | $0.17 | $-0.22 | · | · | · | · | · | · | · | |
| Cash / Share | $0.56 | $0.24 | $0.93 | $1.73 | $1.79 | $2.32 | $1.54 | $0.97 | $0.65 | $0.47 | $0.58 | $0.67 | |
| EPS (TTM) | $-0.50 | $-0.89 | $-1.12 | $-0.51 | $-0.33 | $-0.40 | $-0.21 | · | · | · | · | · |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 18.6% | -15.4% | -49.4% | 32.3% | 51.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -20.2% | -17.3% | 0.52% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.38% | · | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $70M | $59M | $70M | $139M | $105M | $69M | $68M | $61M | $50M | $49M | $42M | $35M | |
| Net Income TTM | $-44M | $-65M | $-76M | $-34M | $-21M | $-24M | $-12M | $-11M | $-23M | $-9M | $-8M | $-19M | |
| Market Cap | $147M | $390M | $213M | $307M | $2.04B | $1.40B | $941M | $912M | $404M | $190M | $171M | $100M | |
| Enterprise Value | $109M | $346M | · | · | · | · | · | · | $373M | · | · | · | |
| P/E | -3.3 | -5.4 | -2.7 | -9.1 | -94.8 | -54.6 | -76.1 | · | · | · | · | · | |
| P/S | 2.1 | 6.6 | 3.0 | 2.2 | 19.4 | 20.3 | 13.8 | 15.0 | 8.1 | 3.9 | 4.1 | 2.8 | |
| P/B | 2.9 | 5.8 | 2.5 | 2.1 | 12.4 | 8.2 | 8.9 | 16.2 | 16.5 | 9.9 | 7.5 | 3.8 | |
| P / Tangible Book | 3.1 | 6.1 | 2.5 | 2.2 | 12.6 | 8.4 | · | · | · | · | · | · | |
| P / Cash Flow | -7.6 | -7.9 | -4.1 | 27.2 | -142.7 | -85.2 | -75.0 | -64.7 | -46.1 | -70.3 | -394.1 | 310.6 | |
| P / FCF | -6.2 | -7.3 | -3.7 | 103.0 | -72.5 | -69.4 | -57.8 | -54.1 | -41.4 | -52.9 | -104.6 | 5247.3 | |
| EV / EBITDA | -3.0 | -6.5 | · | · | · | · | · | · | -16.2 | · | · | · | |
| EV / FCF | -4.6 | -6.4 | · | · | · | · | · | · | -38.3 | · | · | · | |
| EV / Revenue | 1.6 | 5.8 | · | · | · | · | · | · | 7.5 | · | · | · | |
| Earnings Yield | -30.7% | -18.7% | -36.7% | -10.9% | -1.1% | -1.8% | -1.3% | · | · | · | · | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $15M | $15M | $39M | $9M | $15M | $8M | $21M | $13M | $8M | $17M | $27M | $9M | $21M | $13M | $30M | $34M | |
| Cost of Revenue | $4M | $2M | $2M | $2M | $2M | $3M | $4M | $4M | $3M | $5M | $3M | $2M | $3M | $5M | $8M | $10M | |
| R&D Expense | $12M | $11M | $12M | $14M | $14M | $13M | $12M | $12M | $11M | $11M | $11M | $14M | $17M | $17M | $20M | $22M | |
| SG&A Expense | $11M | $10M | $11M | $11M | $12M | $12M | $13M | $14M | $16M | $13M | $12M | $12M | $13M | $15M | $12M | $13M | |
| Operating Expenses | $26M | $23M | $28M | $28M | $28M | $28M | $29M | $29M | $31M | $29M | $26M | $41M | $34M | $37M | $44M | $45M | |
| Operating Income | $-11M | $-8M | $11M | $-19M | $-13M | $-20M | $-7M | $-17M | $-23M | $-12M | $282.0K | $-32M | $-13M | $-24M | $-13M | $-11M | |
| Interest Income | $535.0K | $665.0K | $656.0K | $634.0K | $584.0K | $751.0K | $940.0K | $849.0K | $972.0K | $909.0K | $906.0K | $1M | $1M | $1M | $823.0K | $436.0K | |
| Other Non-op | $-1M | $-1M | $-2M | $-1M | $-984.0K | $-942.0K | $-4M | $-5M | $-985.0K | $-516.0K | $-8M | $-4M | $-9.0K | $-25.0K | $-26.0K | $216.0K | |
| Pretax Income | $-12M | $-9M | $10M | $-20M | $-13M | $-21M | $-10M | $-21M | $-23M | $-11M | $-7M | $-35M | $-12M | $-23M | $-12M | $-10M | |
| Income Tax | $10.0K | $36.0K | $18.0K | $8.0K | $10.0K | $11.0K | $4.0K | $10.0K | $10.0K | $10.0K | $35.0K | $9.0K | $9.0K | $16.0K | $151.0K | $8.0K | |
| Net Income | $-12M | $-9M | $10M | $-20M | $-13M | $-21M | $-10M | $-21M | $-23M | $-12M | $-7M | $-35M | $-12M | $-23M | $-13M | $-10M | |
| EPS (Basic) | $-0.13 | $-0.10 | $0.13 | $-0.22 | $-0.16 | $-0.25 | $-0.12 | $-0.29 | $-0.32 | $-0.16 | $-0.11 | $-0.50 | $-0.17 | $-0.34 | $-0.19 | $-0.15 | |
| EPS (Diluted) | $-0.13 | $-0.10 | $0.13 | $-0.22 | $-0.16 | $-0.25 | $-0.12 | $-0.29 | $-0.32 | $-0.16 | $-0.11 | $-0.50 | $-0.17 | $-0.34 | $-0.19 | $-0.15 | |
| Shares (Basic) | 91,053,000 | 90,768,000 | · | 90,251,000 | 85,389,000 | 82,410,000 | · | 72,032,000 | 70,376,000 | 69,854,000 | · | 69,466,000 | 67,573,000 | 65,931,000 | · | 65,426,000 | |
| Shares (Diluted) | 91,053,000 | 90,768,000 | · | 90,251,000 | 85,389,000 | 82,410,000 | · | 72,032,000 | 70,376,000 | 69,854,000 | · | 69,466,000 | 67,573,000 | 65,931,000 | · | 65,426,000 | |
| EBITDA | $-11M | · | · | $-19M | $-13M | $-19M | · | $-17M | $-23M | $-12M | · | $-32M | $-13M | $-24M | · | $-11M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $27M | $37M | $51M | $25M | $27M | $18M | $19M | $37M | $19M | $58M | $65M | $75M | $92M | $103M | $114M | $109M | |
| Short-term Investments | $28M | $29M | $27M | $33M | $40M | $41M | $54M | $53M | $55M | $27M | · | · | · | · | · | · | |
| Inventory | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Prepaid Expense | $3M | $4M | $6M | $5M | $3M | $4M | $4M | $3M | $3M | $5M | · | $5M | $4M | $5M | · | $5M | |
| Other Current Assets | $500.0K | $400.0K | $500.0K | $500.0K | $100.0K | $500.0K | $500.0K | $300.0K | $900.0K | $500.0K | · | · | · | · | · | · | |
| Current Assets | $72M | $80M | $97M | $76M | $89M | $78M | $99M | $113M | $91M | $108M | · | $103M | $120M | $130M | · | $146M | |
| PP&E (Net) | $12M | $13M | $13M | $14M | $15M | $16M | $14M | $13M | $14M | $15M | · | $15M | $23M | $24M | · | $23M | |
| PP&E (Gross) | $59M | $59M | $58M | $58M | $58M | $57M | $55M | $54M | $54M | $55M | · | $54M | $66M | $65M | · | $63M | |
| Accum. Depreciation | $47M | $46M | $45M | $44M | $43M | $42M | $41M | $41M | $40M | $40M | · | $39M | $42M | $41M | · | $39M | |
| Goodwill | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $3M | $3M | $3M | $3M | |
| Other Non-current Assets | $1M | $994.0K | $883.0K | $912.0K | $950.0K | $967.0K | $1M | $2M | $2M | $1M | · | $726.0K | $498.0K | $415.0K | · | $208.0K | |
| Total Assets | $120M | $129M | $148M | $124M | $138M | $129M | $149M | $148M | $132M | $150M | · | $154M | $207M | $218M | · | $235M | |
| Accounts Payable | $3M | $2M | $2M | $2M | $1M | $6M | $3M | $4M | $4M | $3M | · | $3M | $4M | $4M | · | $3M | |
| Accrued Liabilities | $3M | $3M | $3M | $3M | $3M | $5M | $6M | $7M | $5M | $5M | · | $9M | $7M | $8M | · | $13M | |
| Current Liabilities | $24M | $15M | $25M | $18M | $15M | $21M | $24M | $35M | $31M | $29M | · | $38M | $36M | $38M | · | $32M | |
| Capital Leases | $28M | $29M | $30M | $26M | $27M | $27M | $28M | $9M | $10M | $11M | · | $13M | $35M | $37M | · | $40M | |
| Other Non-current Liabilities | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Total Liabilities | $87M | $86M | $97M | $85M | $83M | $79M | $82M | $75M | $71M | $70M | · | $63M | $83M | $92M | · | $81M | |
| Long-term Debt | $41M | $40M | $40M | $40M | $39M | $29M | · | $29M | $28M | $28M | · | · | · | · | · | · | |
| Total Debt | $41M | · | · | $40M | $39M | $29M | · | $29M | $28M | $28M | · | · | · | · | · | · | |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Paid-in Capital | $660M | $659M | $657M | $655M | $652M | $633M | $630M | $626M | $593M | $588M | · | $582M | $580M | $570M | · | $563M | |
| Retained Earnings | $-627M | $-615M | $-607M | $-616M | $-597M | $-583M | $-563M | $-552M | $-532M | $-509M | · | $-490M | $-455M | $-444M | · | $-409M | |
| AOCI | $-13.0K | $-11.0K | $8.0K | $12.0K | $-3.0K | $14.0K | $52.0K | $126.0K | $-23.0K | $-16.0K | · | · | · | · | · | · | |
| Stockholders' Equity | $33M | $43M | $51M | $39M | $56M | $50M | $67M | $73M | $61M | $79M | $87M | $92M | $124M | $126M | $145M | $154M | |
| Liabilities + Equity | $120M | $129M | $148M | $124M | $138M | $129M | $149M | $148M | $132M | $150M | · | $154M | $207M | $218M | · | $235M | |
| Shares Outstanding | 91,388,000 | 90,894,000 | 90,478,000 | 90,281,000 | 90,254,000 | 82,841,000 | 81,850,000 | 81,376,000 | 70,914,000 | 70,554,000 | · | 69,827,000 | 69,804,000 | 66,696,000 | · | 65,613,000 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | · | · | · | |
| Stock-based Comp | $2M | $1M | $2M | $3M | $3M | $2M | $3M | $3M | $5M | $3M | $2M | $2M | $3M | $3M | $3M | $5M | |
| Restructuring | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $3M | $72.0K | $72.0K | $3M | $0 | |
| Other Non-cash | · | · | · | · | · | $3M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-10M | $-13M | $20M | $-8M | $-18M | $-14M | $-16M | $-13M | $-12M | $-8M | $-11M | $-16M | $-16M | $-9M | $5M | $20M | |
| CapEx | $898.0K | $176.0K | $520.0K | $182.0K | $3M | $1M | $2M | $1M | $395.0K | $1M | $-380.0K | $678.0K | $2M | $3M | $-33.0K | $1M | |
| Investing Cash Flow | $175.0K | $-1M | $6M | $6M | $-367.0K | $12M | $-3M | $2M | $-27M | $-29M | $1M | $-1M | $-2M | $-3M | $33.0K | $-1M | |
| Debt Issued | · | · | $0 | $0 | $10M | $0 | $0 | $0 | $0 | $30M | $0 | $0 | $0 | $0 | · | · | |
| Net Debt Issued | · | · | · | · | · | $0 | · | · | · | $30M | · | · | · | · | · | · | |
| Stock Issued | · | · | $-1.0K | $0 | · | · | $-1.0K | $31M | $0 | $0 | $0 | $0 | $7M | $2M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $2M | · | · | |
| Financing Cash Flow | $66.0K | $-14.0K | $180.0K | $-111.0K | $27M | $1M | $1M | $30M | $-197.0K | $29M | $0 | $-108.0K | $7M | $1M | $339.0K | $133.0K | |
| Net Change in Cash | $-9M | $-14M | $26M | $-1M | $8M | $-944.0K | $-18M | $19M | $-39M | $-7M | $-10M | $-18M | $-11M | $-11M | $5M | $19M | |
| Taxes Paid | · | · | · | · | · | $0 | · | · | · | $17.0K | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | $-15M | · | · | · | $-9M | · | · | · | $-12M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -75.3% | · | · | -220.3% | -83.9% | -271.6% | · | -129.0% | -284.9% | -69.6% | · | -345.6% | -59.2% | -182.3% | · | -30.9% | |
| Net Margin | -80.5% | · | · | -228.1% | -86.6% | -274.3% | · | -160.8% | -285.2% | -67.4% | · | -376.3% | -54.0% | -174.2% | · | -29.0% | |
| Pretax Margin | -80.4% | · | · | -228.0% | -86.5% | -274.1% | · | -160.8% | -285.1% | -67.3% | · | -376.2% | -54.0% | -174.1% | · | -29.0% | |
| EBITDA Margin | -75.3% | · | · | -220.3% | -83.9% | -255.8% | · | -129.0% | -284.9% | -69.6% | · | -345.6% | -59.2% | -182.3% | · | -30.9% | |
| ROA | -9.3% | · | · | -14.4% | -9.8% | -14.9% | · | -13.6% | -13.4% | -6.3% | · | -17.9% | -5.2% | -10.0% | · | -4.3% | |
| ROE | -27.1% | · | · | -35.0% | -22.7% | -32.1% | · | -25.0% | -24.5% | -11.2% | · | -28.4% | -8.1% | -15.9% | · | -6.2% | |
| ROIC | -15.2% | · | · | -24.2% | -13.6% | -26.0% | · | -16.2% | -25.3% | -11.1% | · | -35.0% | -10.2% | -18.8% | · | -6.9% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | · | · | 4.1 | 5.8 | 3.7 | · | 3.2 | 3.0 | 3.7 | · | 2.7 | 3.4 | 3.4 | · | 4.6 | |
| Quick Ratio | 2.3 | · | · | 3.2 | 4.4 | 2.9 | · | 2.6 | 2.4 | 2.9 | · | 1.9 | 2.6 | 2.7 | · | 3.4 | |
| Debt / Equity | 1.2 | · | · | 1.0 | 0.7 | 0.6 | · | 0.4 | 0.5 | 0.4 | · | · | · | · | · | · | |
| LT Debt / Equity | 1.0 | · | · | 1.0 | 0.7 | 0.6 | · | 0.4 | 0.5 | 0.4 | · | · | · | · | · | · |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.1 | · | 0.0 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 2.0 | · | · | 1.2 | 1.0 | 1.3 | · | 2.0 | 1.6 | 2.2 | · | 1.1 | 1.7 | 2.5 | · | 7.2 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.36 | · | · | $0.43 | $0.62 | $0.60 | · | $0.90 | $0.87 | $1.12 | · | $1.31 | $1.78 | $1.89 | · | $2.35 | |
| Revenue / Share | $0.16 | · | · | $0.10 | $0.18 | $0.09 | · | $0.18 | $0.11 | $0.24 | · | $0.13 | $0.32 | $0.20 | · | $0.53 | |
| Cash Flow / Share | · | · | · | · | · | $-0.17 | · | · | · | $-0.11 | · | · | · | $-0.14 | · | · | |
| Cash / Share | $0.30 | · | · | $0.28 | $0.30 | $0.22 | · | $0.46 | $0.26 | $0.82 | · | $1.07 | $1.32 | $1.54 | · | $1.66 | |
| EPS (TTM) | $-0.32 | $-0.73 | · | $-0.75 | $-0.82 | $-0.98 | · | $-0.88 | $-1.09 | $-0.94 | · | $-1.20 | $-0.85 | $-0.72 | · | $-0.47 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $78M | $47M | · | $53M | $57M | $50M | · | $64M | $61M | $74M | · | $74M | $99M | $116M | · | $133M | |
| Net Income TTM | $-31M | $-62M | · | $-64M | $-65M | $-74M | · | $-62M | $-76M | $-65M | · | $-82M | $-57M | $-48M | · | $-31M | |
| Market Cap | $207M | · | · | $220M | $220M | $223M | · | $251M | $220M | $246M | · | $132M | $195M | $276M | · | $398M | |
| Enterprise Value | $192M | · | · | $201M | $193M | $192M | · | $189M | $175M | $189M | · | · | · | · | · | · | |
| P/E | -7.1 | -2.2 | · | -3.3 | -3.0 | -2.7 | · | -3.5 | -2.8 | -3.7 | · | -1.6 | -3.3 | -5.8 | · | -12.9 | |
| P/S | 2.7 | · | · | 4.2 | 3.9 | 4.5 | · | 3.9 | 3.6 | 3.3 | · | 1.8 | 2.0 | 2.4 | · | 3.0 | |
| P/B | 6.3 | · | · | 5.7 | 4.0 | 4.5 | · | 3.4 | 3.6 | 3.1 | · | 1.4 | 1.6 | 2.2 | · | 2.6 | |
| P / Tangible Book | 6.8 | 3.6 | · | 6.1 | 4.1 | 4.7 | · | 3.5 | 3.7 | 3.2 | · | 1.5 | 1.6 | 2.2 | · | 2.6 | |
| P / Cash Flow | · | · | · | · | · | -16.2 | · | · | · | -31.6 | · | · | · | -30.0 | · | · | |
| EV / Revenue | 2.5 | · | · | 3.8 | 3.4 | 3.9 | · | 2.9 | 2.9 | 2.5 | · | · | · | · | · | · | |
| Earnings Yield | -14.2% | -44.8% | · | -30.7% | -33.6% | -36.4% | · | -28.6% | -35.2% | -26.9% | · | -63.5% | -30.4% | -17.4% | · | -7.8% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $70M | $59M | $70M | $139M | $105M |
| Margin Operasi % | -59.3% | -98.6% | -97.0% | -25.2% | -21.7% |
| Laba Bersih | $-44M | $-65M | $-76M | $-34M | $-21M |
| EPS Dilusian | $-0.50 | $-0.89 | $-1.12 | $-0.51 | $-0.33 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utang / Ekuitas | 0.8 | 0.4 | · | · | · |
| Rasio Lancar | 3.8 | 4.2 | 2.6 | 3.3 | 4.9 |
| Rasio Cepat | 3.1 | 3.1 | 2.1 | 3.0 | 4.2 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-24M | $-54M | $-57M | $3M | $-28M |
Pemilik institusional (13F) 155 pengaju · $154.0M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
155
Nilai yang dipegang
$154.0M
Posisi baru
29
Posisi yang keluar
11
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 29 (-4 vs Kuartal sebelumnya) | 11 (-10 vs Kuartal sebelumnya) | 61 (+13 vs Kuartal sebelumnya) | 36 (+4 vs Kuartal sebelumnya) | +3.0M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| BlackRock, Inc. | $16.462.635 | 7.284.352 | 10,69% | Saham |
| Opaleye Management Inc. | $15.334.100 | 6.785.000 | 9,96% | Saham |
| Aberdeen Group plc | $15.300.096 | 6.769.954 | 9,94% | Saham |
| MILLENNIUM MANAGEMENT LLC | $12.541.054 | 5.549.139 | 8,15% | Saham |
| Telemark Asset Management, LLC | $8.692.889 | 3.846.411 | 5,65% | Saham |
| AMERIPRISE FINANCIAL INC | $8.609.334 | 3.809.440 | 5,59% | Saham |
| Nantahala Capital Management, LLC | $8.189.365 | 3.623.613 | 5,32% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.174.666 | 3.617.109 | 5,31% | Saham |
| VANGUARD GROUP INC | $8.054.714 | 4.941.542 | 5,23% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $4.887.990 | 2.162.393 | 3,17% | Saham |
| STATE STREET CORP | $3.970.400 | 1.756.814 | 2,58% | Saham |
| D. E. Shaw & Co., Inc. | $3.032.952 | 1.342.014 | 1,97% | Saham |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3.006.263 | 1.330.205 | 1,95% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.954.206 | 1.307.171 | 1,92% | Saham |
| Assenagon Asset Management S.A. | $2.888.746 | 1.278.206 | 1,88% | Saham |
| AQR CAPITAL MANAGEMENT LLC | $1.910.675 | 845.431 | 1,24% | Saham |
| TWO SIGMA INVESTMENTS, LP | $1.574.314 | 696.599 | 1,02% | Saham |
| NORTHERN TRUST CORP | $1.543.444 | 682.940 | 1,00% | Saham |
| FRANKLIN RESOURCES INC | $1.533.726 | 678.640 | 1,00% | Saham |
| MORGAN STANLEY | $1.467.125 | 649.170 | 0,95% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $1.313.191 | 581.058 | 0,85% | Saham |
| Man Group plc | $1.278.240 | 565.593 | 0,83% | Saham |
| Post Resch Tallon Group Inc. | $1.273.460 | 563.478 | 0,83% | Saham |
| PERKINS CAPITAL MANAGEMENT INC | $1.188.986 | 526.100 | 0,77% | Saham |
| FMR LLC | $1.081.371 | 478.483 | 0,70% | Saham |
| GOLDMAN SACHS GROUP INC | $982.929 | 434.924 | 0,64% | Saham |
| ALGERT GLOBAL LLC | $973.857 | 430.910 | 0,63% | Saham |
| Nuveen, LLC | $886.524 | 392.267 | 0,58% | Saham |
| TUDOR INVESTMENT CORP ET AL | $808.910 | 357.925 | 0,53% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $708.690 | 313.386 | 0,46% | Saham |
| Russell Investments Group, Ltd. | $696.292 | 308.095 | 0,45% | Saham |
| PLATINUM INVESTMENT MANAGEMENT LTD | $597.689 | 264.464 | 0,39% | Saham |
| ROYAL BANK OF CANADA | $594.000 | 262.926 | 0,39% | Saham |
| Potomac Capital Management, Inc. | $587.600 | 260.000 | 0,38% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $547.397 | 242.211 | 0,36% | Saham |
| XTX Topco Ltd | $543.817 | 240.627 | 0,35% | Saham |
| BANK OF AMERICA CORP /DE/ | $543.568 | 240.517 | 0,35% | Saham |
| UBS Group AG | $542.190 | 239.907 | 0,35% | Saham |
| Bank of New York Mellon Corp | $510.849 | 226.039 | 0,33% | Saham |
| CITADEL ADVISORS LLC | $432.971 | 191.580 | 0,28% | Saham |
| Invesco Ltd. | $366.732 | 162.271 | 0,24% | Saham |
| Cubist Systematic Strategies, LLC | $359.610 | 147.381 | 0,23% | Saham |
| BARCLAYS PLC | $350.920 | 155.274 | 0,23% | Saham |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $334.595 | 148.051 | 0,22% | Saham |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $284.552 | 125.908 | 0,18% | Saham |
| STRS OHIO | $273.460 | 121.000 | 0,18% | Saham |
| JANE STREET GROUP, LLC | $273.042 | 120.815 | 0,18% | Saham |
| MARSHALL WACE, LLP | $264.726 | 117.135 | 0,17% | Saham |
| Stonepine Capital Management, LLC | $247.836 | 109.662 | 0,16% | Saham |
| RHUMBLINE ADVISERS | $233.449 | 103.301 | 0,15% | Saham |
Aktivis & pemilik 5%+ 3 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| John Nicols | 16 Feb. 2021 | · | Pengajuan awal | Investasi pasif | SEC |
| – I.RS. IDENTIFICATION NO. OF ABOVE PERSON RAÍZEN ENERGIA S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON SHELL BRAZIL HOLDING B.V., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ROYAL DUTCH SHELL PLC, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN S.A. INDUSTRIA E COMÉRCIO, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN INVESTIMENTOS E PARTICIPAÇÕES S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN LIMITED ×2 pengajuan | 26 Mei 2015 | · | Pengajuan awal | · | SEC |
| – I.RS. IDENTIFICATION NO. OF ABOVE PERSON RAIZEN ENERGIA PARTICIPA Ç Õ ES S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ISPAGNAC PARTICIPA Ç Õ ES LTDA., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ROYAL DUTCH SHELL PLC, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN S.A. INDUSTRIA E COM É RCIO, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN LIMITED | 7 Juni 2011 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 44 orang dalam · 19 pejabat · 22 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Alison Moore | President and CEO | 23 Feb. 2026 A | 250.506 | 0 | 2 | $-20.672 |
| Peter M Strumph | Interim President and CEO | 1 Juni 2012 A | 60.756 | 0 | 0 | $0 |
| Alan Shaw | President and CEO | 16 Des. 2011 S | 202.000 | 0 | 0 | $0 |
| Georgia Erbez | Chief Financial Officer and Chief Business Officer | 23 Feb. 2026 A | 66.810 | 0 | 2 | $-20.610 |
| Sriram Ryali | Chief Financial Officer | 1 Jan. 2024 A | 175.791 | 0 | 0 | $0 |
| Gordon Sangster | SVP & Chief Financial Officer | 21 Maret 2019 M | 134.453 | 0 | 0 | $0 |
| David D O'Toole | SVP & Chief Financial Officer | 4 Sep. 2013 F | 110.687 | 0 | 0 | $0 |
| Brian Paul Dowd | Interim CFO | 1 Juni 2012 A | 28.310 | 0 | 0 | $0 |
| Robert J Lawson | SVP and CFO | 11 Mei 2011 P | 44.000 | 0 | 0 | $0 |
| Kevin Norrett | Chief Operating Officer | 5 Feb. 2025 A | 177.327 | 0 | 0 | $0 |
| Stefan Lutz | Chief Scientific Officer | 23 Feb. 2026 A | 130.421 | 0 | 3 | $-17.853 |
| Margaret Nell Fitzgerald | Chief Legal and Compliance Officer | 1 Jan. 2024 A | 133.770 | 0 | 0 | $0 |
| James Lalonde | SVP, R&D | 14 Mei 2019 M | 133.402 | 0 | 0 | $0 |
| Michael D. Aldridge | Senior Vice President, Corporate & Strategic Development | 17 Mei 2018 M | 0 | 0 | 0 | $0 |
| Douglas T. Sheehy | EVP, Chief Administrative Officer, General Counsel & Secretary | 5 Maret 2016 F | 247.617 | 0 | 0 | $0 |
| Matthew Tobin | SVP, Research & Development | 16 Mei 2013 M | 78.707 | 0 | 0 | $0 |
| David L. Anton | SVP, BioIndustrials | 10 Feb. 2013 F | 93.777 | 0 | 0 | $0 |
| Seufer-Wasserthal Peter | SVP, Pharmaceuticals | 24 Jan. 2013 A | 93.064 | 0 | 0 | $0 |
| Joseph J. Sarret | SVP and CBO | 7 Maret 2012 A | 74.000 | 0 | 0 | $0 |
| Raymond De Vre | Direktur | 17 Juni 2026 A | 84.811 | 0 | 2 | $-8.633 |
| Esther Martinborough | Direktur | 17 Juni 2026 A | 129.036 | 0 | 0 | $0 |
| Christos Richards | Direktur | 17 Juni 2026 A | 85.133 | 0 | 0 | $0 |
| Cynthia Collins | Direktur | 17 Juni 2026 A | 112.157 | 0 | 0 | $0 |
| Stephen George Dilly | Direktur | 17 Juni 2026 A | 727.053 | 0 | 0 | $0 |
| Rahul Singhvi | Direktur | 17 Juni 2026 A | 137.052 | 0 | 0 | $0 |
| David V Smith | Direktur | 17 Juni 2026 A | 105.705 | 0 | 0 | $0 |
| PARKER H STEWART | Direktur | 17 Juni 2026 A | 143.583 | 0 | 0 | $0 |
| Dennis P Wolf | Direktur | 21 Nov. 2025 S | 138.951 | 0 | 1 | $-13.965 |
| Byron L Dorgan | Direktur | 11 Juni 2024 A | 223.581 | 0 | 0 | $0 |
| Jennifer Aaker | Direktur | 13 Juni 2023 A | 66.211 | 0 | 0 | $0 |
| John J Nicols | Direktur | 18 April 2023 M | 783.965 | 0 | 0 | $0 |
| Patrick Y Yang | Direktur | 14 Juni 2022 A | 53.785 | 0 | 0 | $0 |
| Bernard J Kelley | Direktur | 10 Agu 2021 M | 206.136 | 0 | 0 | $0 |
| Thomas R Baruch | Direktur | 12 Juni 2020 S | 33.093 | 0 | 0 | $0 |
| Pam P. Cheng | Direktur | 11 Juni 2019 A | 69.589 | 0 | 0 | $0 |
| Kathleen Sereda Glaub | Direktur | 11 Juni 2019 A | 68.481 | 0 | 0 | $0 |
| Alexander Karsner | Direktur | 2 Jan. 2014 A | 78.519 | 0 | 0 | $0 |
| Bruce A Pasternack | Direktur | 24 Agu 2010 P | 10.000 | 0 | 0 | $0 |
| James R Sulat | Direktur | 27 April 2010 J | 5.957.108 | 0 | 0 | $0 |
| Opaleye Management Inc. | Pemilik 10% | 1 Des. 2025 S | 179.989 | 0 | 27 | $-7.596.890 |
| Brazil Holding B.V. Shell | Pemilik 10% | 31 Mei 2011 J | 5.573.319 | 0 | 0 | $0 |
| Equilon Enterprises LLC | Pemilik 10% | 20 Mei 2011 J | 5.573.319 | 0 | 0 | $0 |
| MAXYGEN INC | Pemilik 10% | 14 Des. 2010 J | 524.643 | 0 | 0 | $0 |
| Dean Ross Taylor JR | · | 7 Feb. 2023 F | 38.554 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 19 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,42% | 70.133 SH | 2 Okt. 2026 | Harian |
| IWC · iShares Trust | 0,03% | 288.891 SH | 11 Sep. 2026 | Harian |
| IBB · iShares Trust | 0,01% | 766.290 SH | 11 Sep. 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 496.936 SH | 19 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 78.444 SH | 19 Agu 2026 | Harian |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,01% | 7.738 SH | 1 Okt. 2026 | Harian |
| IWO · iShares Trust | 0,01% | 696.097 SH | 11 Sep. 2026 | Harian |
| IWM · iShares Trust | 0,00% | 2.244.630 SH | 11 Sep. 2026 | Harian |
| RSSL · Global X Funds | 0,00% | 41.308 NS | 31 Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 69.999 SH | 2 Okt. 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,00% | 52.788 NS | 31 Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 17.106 SH | 3 Sep. 2026 | Harian |
| DFAC · Dimensional ETF Trust | 0,00% | 19.277 NS | 31 Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.729 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 895.869 SH | 19 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.633.770 SH | 19 Agu 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.454 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.744 SH | 19 Agu 2026 | Harian |
| IWN · iShares Trust | · | 129.318 SH | 11 Sep. 2026 | Harian |
CDXS Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 13 analis
BELI
Target median
$5.00
+267,6%
4 30,8%
Beli Kuat
6 46,2%
Beli
3 23,1%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
7 analis · 2026-10-01Target rata-rata $6.14 +351,7%
← Di bawah semua target
Harga saat ini $1.36
Rendah$2.00
Rata-rata$6.14
Tinggi$11.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| CDXS | $147M | -3.3 | 18.6% | -62.5% | -82.8% | · |
| LAB | $495M | -6.4 | -6.2% | -87.8% | -17.6% | 49.9% |
| QSI | · | · | · | · | · | · |
| LFCR | $249M | -5.3 | 0.47% | -30.0% | -461.3% | 31.3% |
| NAUT | $247M | -4.1 | · | · | -34.9% | · |
| QTRX | $297M | -2.5 | 1.1% | -77.1% | -36.4% | 46.8% |
| SEER | · | -1.4 | 17.0% | · | · | · |
| MXCT | $166M | -3.7 | -14.5% | -135.1% | -24.6% | 81.2% |
| CSBR | $83M | -74.5 | 4.4% | -2.0% | -30.5% | · |
| HYFT | · | · | · | -89.7% | -78.9% | 58.8% |
| CIRC | · | · | · | · | · | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 11, 2026